NDC 47426-201

Cinvanti 130 mg per 18 mL injection, emulsion

On the label: Heron Therapeutics, Inc..

United States: 2India: 2

Where it's made

FactoryWhereRoleLast FDA inspection
Alcami Carolinas CorporationCharleston, SC, United StatesMakes it Problems found, fixed voluntarilyFeb 6, 2026 · 9 inspections
Alivus Life Sciences LimitedAnkleshwar, IndiaMakes the active ingredient Problems found, fixed voluntarilyJan 31, 2025 · 5 inspections
Curia New Mexico, LLCAlbuquerque, NM, United StatesMakes it Problems found, fixed voluntarilyJun 28, 2024 · 10 inspections
MSN Pharmachem Private LimitedSangareddy District, IndiaMakes the active ingredient Problems found, fixed voluntarilyApr 21, 2023 · 4 inspections
Alcami Carolinas CorporationWilmington, NC, United StatesLabels it Problems found, fixed voluntarilySep 26, 2025 · 11 inspections
Alcami Carolinas CorporationWilmington, NC, United StatesTests it Problems found, fixed voluntarilySep 26, 2025 · 11 inspections
Eurofins BioPharma Product Testing Columbia, LLCColumbia, MO, United StatesTests it No problems foundJan 14, 2022 · 5 inspections
Particle Technology LabsDowners Grove, IL, United StatesTests it No problems foundFeb 20, 2026 · 7 inspections
Pharma Packaging Solutions, LLCClinton, TN, United StatesLabels it No problems foundJun 28, 2023 · 4 inspections
SGS North America Inc.Lincolnshire, IL, United StatesTests it Problems found, fixed voluntarilyMar 20, 2026 · 9 inspections
SPS Pharma ServicesLocation not on fileTests it Not inspected on record

Product details

Generic drug
Aprepitant: every company that makes it
Form
injection, emulsion, intravenous
Strength
130 mg per 18 mL
Approval
NDA NDA209296
On the market since
Jan 3, 2018
Package NDCs
47426-201-01
Official label
DailyMed (National Library of Medicine), updated Apr 1, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?